Cutaneous tumors, staging and procedural principles
Dermato-oncology begins with clinical evolution, lesion morphology, dermoscopy and an appropriately obtained tissue diagnosis. Basal cell carcinoma can show a pearly edge, telangiectasia, ulceration, arborizing vessels and blue-gray structures; it is usually locally destructive and only rarely metastatic. Squamous cell carcinoma requires attention to invasion and high-risk features such as differentiation, perineural involvement, depth, site and immunosuppression. A lesion with a keratin crater can resemble a keratoacanthoma or an invasive squamous malignancy, so appearance alone is not adequate justification for destructive treatment without an appropriate diagnostic plan.
Melanoma can be pigmented or amelanotic. Evolution and comparison with the person's other lesions matter; a lesion does not need to satisfy every letter of a mnemonic or exceed a fixed diameter to be important. Histological staging includes Breslow thickness and ulceration together with nodal and other disease information. A method that supplies adequate diagnostic and microstaging information is central. A narrow complete diagnostic excision is often preferred when feasible, but a categorical ban on every deep shave or partial biopsy is inaccurate. Selected difficult sites and large lesions can require a different adequately planned sampling technique. A superficial sample that transects a suspected invasive tumor can limit staging.
A diagnostic biopsy margin, a definitive therapeutic excision margin and a pathological clearance measurement are different quantities. Definitive management uses the actual tumor type, stage, risk, site and applicable current framework rather than one margin for all skin cancers. Mohs and other staged margin-controlled methods can conserve tissue and assess relevant margins in selected settings, but a named technique does not eliminate recurrence or every complication. The suitability of sentinel-node assessment requires stage-specific discussion rather than a thickness value functioning as an automatic treatment order.
Cutaneous lymphoma, Merkel cell carcinoma, vascular tumors and adnexal neoplasms need their own clinicopathological context. A self-regressing CD30-positive eruption can have an indolent course while still requiring follow-up for associated lymphoproliferative disease. Immunohistochemical profiles guide a differential but should not be treated as proof independent of tissue quality, clinical staging and alternative explanations. Surgical planning also includes site verification, consent, hemostatic risks, wound factors and histological follow-up. Do not stop an anticoagulant or choose a local-anesthetic dose from a generic paragraph without evaluating the actual procedure and patient.